Check out these key findings about TC Biopharm (Holdings) Plc (TCBP)

TC Biopharm (Holdings) Plc (NASDAQ: TCBP) stock jumped 1.00% on Monday to $0.47 against a previous-day closing price of $0.47. With 0.18 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.65 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.5000 whereas the lowest price it dropped to was $0.4502. The 52-week range on TCBP shows that it touched its highest point at $16.92 and its lowest point at $0.42 during that stretch. It currently has a 1-year price target of $7.00. Beta for the stock currently stands at 0.37.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TCBP was down-trending over the past week, with a drop of -3.08%, but this was down by -6.86% over a month. Three-month performance dropped to -22.15% while six-month performance fell -87.06%. The stock lost -97.08% in the past year, while it has lost -87.66% so far this year. A look at the trailing 12-month EPS for TCBP yields -0.69 with Next year EPS estimates of -4.60.

Float and Shares Shorts:

At present, 2.48 million TCBP shares are outstanding with a float of 2.19 million shares on hand for trading. On Aug 30, 2023, short shares totaled 34660.0, which was 0.48% higher than short shares on Jul 30, 2023.

Institutional Ownership:

Through their ownership of 5.23% of TCBP’s outstanding shares, institutional investors have minority control over the company. Other institutions hold — of TCBP, in contrast to — held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in TCBP with 9.27% of the stake, Armistice Capital LLC holds 528,313 shares worth 528,313. A second-largest stockholder of TCBP, Citadel Securities LLC, holds 75,295 shares, controlling over 1.32% of the firm’s shares. Renaissance Technologies LLC is the third largest shareholder in TCBP, holding 71,900 shares or 1.26% stake.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TCBP since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With TCBP analysts setting a high price target of $5.61 and a low target of $5.61, the average target price over the next 12 months is $5.61. Based on these targets, TCBP could surge 1093.62% to reach the target high and rise by 1093.62% to reach the target low. Reaching the average price target will result in a growth of 1093.62% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Leave a Comment

Your email address will not be published. Required fields are marked *